Private Advisor Group’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Private Advisor Group’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.22M	Buy	63,697 +7,920	+14%	+$464K	0.02%	697
2026 Q1	$3.02M	Buy	+55,777	New	+$3.11M	0.01%	854
2022 Q1	–	Sell	-41,781	Closed	-$1.93M	–	2299
2021 Q4	$1.93M	Sell	41,781 -1,061	-2%	-$50.3K	0.01%	825
2021 Q3	$2.03M	Buy	42,842 +14,474	+51%	+$719K	0.01%	875
2021 Q2	$1.47M	Buy	28,368 +377	+1%	+$18.9K	0.01%	877
2021 Q1	$1.41M	Buy	27,991 +414	+2%	+$22.1K	0.01%	852
2020 Q4	$1.44M	Buy	+27,577	New	+$1.32M	0.02%	773
2020 Q3	–	Sell	-1,750	Closed	-$75K	–	3450
2020 Q2	$75K	Buy	+1,750	New	+$72.3K	﹤0.01%	1879
2018 Q3	–	Sell	-21,759	Closed	-$939K	–	1657
2018 Q2	$939K	Buy	+21,759	New	+$914K	0.02%	505
2016 Q1	–	Sell	-4,506	Closed	-$231K	–	1144
2015 Q4	$231K	Buy	4,506 +115	+3%	+$5.86K	0.01%	884
2015 Q3	$206K	Buy	4,391 +713	+19%	+$43K	0.01%	876
2015 Q2	$229K	Buy	+3,678	New	+$229K	0.01%	892
2014 Q4	–	Sell	-488	Closed	-$26K	–	1309
2014 Q3	$26K	Buy	+488	New	+$24.8K	﹤0.01%	1114
2014 Q1	–	Sell	-64,436	Closed	-$2.83M	–	852
2013 Q4	$2.83M	Buy	+64,436	New	+$2.68M	0.32%	68

Other funds holding XPH

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

KWM

Kingsview Wealth Management Grants Pass, Oregon $8.25B AUM 24.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Evelyn Partners London $46.9B AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Private Advisor Group's XPH Position: Q2 2026 in Review

Private Advisor Group increased its State Street SPDR S&P Pharmaceuticals ETF (XPH) stake by 14% in Q2 2026, buying an estimated $464K and bringing the position to 63,697 shares worth $4.22M. The position accounts for 0.02% of the portfolio, ranked #697.

Private Advisor Group first reported a position in XPH in Q4 2013 and has held it in 14 quarters since. 93 funds tracked by Wall St. Rank hold XPH as of Q2 2026.

Private Advisor Group held 63,697 shares of State Street SPDR S&P Pharmaceuticals ETF worth $4.22M as of Q2 2026.
Private Advisor Group bought 7,920 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2026, an estimated $464K.
State Street SPDR S&P Pharmaceuticals ETF made up 0.02% of Private Advisor Group's portfolio in Q2 2026, its #697 holding.
Private Advisor Group first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2013 and has held it in 14 quarters since.
93 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.